Table 2.
The clinical characteristics of colon cancer patients in the training and validation group.
| Characteristics | Training group No. | % | Validation group No. | % | P-value |
|---|---|---|---|---|---|
| Age | – | – | – | – | – |
| <=65 | 81 | 36.32 | 102 | 45.74 | >0.05 |
| >65 | 142 | 63.68 | 121 | 54.26 | – |
| Gender | – | – | – | – | – |
| Female | 102 | 45.74 | 110 | 49.33 | >0.05 |
| Male | 121 | 54.26 | 113 | 50.67 | – |
| AJCC Stage | – | – | – | – | – |
| I | 35 | 15.7 | 40 | 17.94 | >0.05 |
| II | 89 | 39.91 | 86 | 38.57 | – |
| III | 64 | 28.7 | 60 | 26.91 | – |
| IV | 30 | 13.45 | 31 | 13.9 | – |
| unknown | 5 | 2.24 | 6 | 2.69 | – |
| T stage | – | – | – | – | – |
| T1 | 6 | 2.69 | 5 | 2.24 | >0.05 |
| T2 | 35 | 15.7 | 41 | 18.39 | – |
| T3 | 156 | 69.96 | 147 | 65.92 | – |
| T4 | 26 | 11.66 | 30 | 13.45 | – |
| N stage | – | – | – | – | – |
| N0 | 131 | 58.74 | 134 | 60.09 | >0.05 |
| N1 | 52 | 23.32 | 50 | 22.42 | – |
| N2 | 40 | 17.94 | 39 | 17.49 | – |
| M stage | – | – | – | – | – |
| M0 | 164 | 73.54 | 165 | 73.99 | >0.05 |
| M1 | 30 | 13.45 | 31 | 13.9 | – |
| unknown | 29 | 13 | 27 | 12.11 | – |